Aggravation of Arrhythmia: A Complication of Antiarrhythmic Drugs

Journal of Cardiovascular Electrophysiology

Volumn 4, Issue 3, 1993, Pages 311-319

  PODRID, PHILIP J ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aggravation of arrhythmia; antiarrhythmic drugs; drug toxicity; myocardial ischemia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; APRINDINE; BEPERDIL; BEPRIDIL; BETANIDINE; CIBENZOLINE; DISOPYRAMIDE; ENCAINIDE; FLECAINIDE; INDECAINIDE; LIDOCAINE; LORCAINIDE; MEXILETINE; MORACIZINE; POTASSIUM ION; PROCAINAMIDE; PROPAFENONE; QUINIDINE; QUINIDINE GLUCONATE; TOCAINIDE; UNCLASSIFIED DRUG; VERAPAMIL;

CONGESTIVE HEART FAILURE; CORONARY ARTERY BLOOD FLOW; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HUMAN; HYPOKALEMIA; REVIEW; RISK FACTOR;

ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; HUMAN; RISK FACTORS;

EID: 0027192128     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1993.tb01233.x     Document Type: Review

References (24)

1. Aggravation and provocation of ventricular arrhythmia by antiarrhythmic drugs
2. Proarrhythmic effects of antiarrhythmic drugs
3. Flecainide‐Its proarrhythmic effect and expected changes on the surface electrocardiogram
4. Treatment of frequent ventricular arrhythmia with encainide, assessment using serial ambulatory electrocardiograms, intracardiac electrophysiologic studies, treadmill exercise tests and radionuclide cineangiographic studies
5. Aggravation of arrhythmia induced with antiarrhythmic drugs during electrophysiologic testing
6. Proarrhythmic responses during electrophysiologic testing
7. Etiology warning signs and therapy of torsades de pointe‐A study often patients
8. Clinical predictors of arrhythmia worsening by antiarrhythmic drugs
9. Preliminary Report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
10. Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy
11. Spatial and temporal heterogeneity of left ventricular perfusion in awake dogs
12. Nonuniform loss of regional flow reserve during myocardial ischemia in dogs
13. + activity in swine
14. Interaction of acidosis and increased extracellular potassium on action potential characteristics and conduction in guinea pig ventricular muscle
15. Effect of graded coronary flow reduction on ionic, electrical, and mechanical indexes of ischemia in the pig
16. Alterations in regional myocardial distribution and arrhythmogenic effects of aprinidine produced by coronary artery occlusion in the dog
17. Effects of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute occlusion in drugs
18. Effect of altering potassium concentration on the action of lidocaine and diphenylhydantoin on rabbit atrial and ventricular muscle
19. Electrophysiology of cardiac arrhythmias IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part A
20. The role of exercise testing in evaluation of arrhythmias
21. Kinetics of use‐dependent ventricular conduction slowing by antiarrhythmic drugs in humans
22. Aggravation of arrhythmia by antiarrhythmic drugs‐Incidence and predictors
23. Proarrhythmic effects of antiarrhythmic drugs in patients with malignant ventricular arrhythmia evaluated by electrophysiologic testing
24. The arrhythmogenicity of antiarrhythmic agents